DSM continues its push into personalized nutrition, steers away from kitchen appliances

December 10, 2019 | Case Study

In 2018, DSM made a series of bets in personalized nutrition, engaging with Mixfit, Tespo, and DeNA Life Science. In 2019, it has reinforced those moves by forming partnerships with Panaceutics and WellMetrix in April and October, respectively, as well as acquiring AVA in November. DSM formed a commercial partnership with Panaceutics, exclusively selling the company's fruit puree pouches in the Americas, Europe, and Asia. Meanwhile, its partnership with WellMetrix is research-focused, looking into the efficacy of the organization's urine-based biomarker analysis versus established urine and blood tests. With the purchase of AVA, DSM is gaining access to an online platform that provides nutrition recommendations and coaching.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978

© 2004-2021 Lux Research, Inc. All Lux Research content is intended only for consumption by Lux Research clients; redistribution is prohibited and copyright is strictly enforced. All material is based on information obtained from sources believed to be reliable but no independent verification has been made, nor is its accuracy or completeness guaranteed. All material is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments.